Mesa Laboratories
MLAB
107 hedge funds and large institutions have $502M invested in Mesa Laboratories in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 46 increasing their positions, 31 reducing their positions, and 9 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 31
0% more funds holding
Funds holding: 107 → 107 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
2.48% less ownership
Funds ownership: 72.78% → 70.3% (-2.5%)
14% less capital invested
Capital invested by funds: $585M → $502M (-$82.8M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$15.2M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$9.4M |
| 3 |
BlackRock
New York
|
+$3.75M |
| 4 |
RA
Royce & Associates
New York
|
+$2.81M |
| 5 |
Millennium Management
New York
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$43.7M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$12.8M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$1.22M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$1.03M |
| 5 |
Morgan Stanley
New York
|
-$692K |
MLAB Hedge Fund Activity: Q3 2018 in Review
107 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q3 2018, worth a combined $502M — down 14% from $585M a quarter earlier.
Fund positioning in MLAB was balanced in Q3 2018: 9 funds opened new positions, 9 closed out, 46 added to existing stakes and 31 trimmed.
The largest buyer was Ranger Investment Management, adding an estimated $15.2M. The largest seller was Fidelity Investments, cutting an estimated $43.7M.
- 107 institutional investors held Mesa Laboratories (MLAB) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $502M of Mesa Laboratories stock for Q3 2018, down 14% quarter-over-quarter.
- 9 funds opened new Mesa Laboratories positions in Q3 2018 and 9 closed out, a net change of 0 holders.
- The largest Mesa Laboratories buyer in Q3 2018 was Ranger Investment Management, an estimated $15.2M added.
- The largest Mesa Laboratories seller in Q3 2018 was Fidelity Investments, an estimated $43.7M sold.
Based on aggregated 13F filings for Q3 2018.